BerandaAVH • ASX
add
AVITA Medical Inc
Tutup sebelumnya
$1,30
Rentang hari
$1,25 - $1,29
Rentang tahun
$1,00 - $3,18
Kapitalisasi pasar
194,68Â jt AUD
Volume Rata-Rata
360,87Â rb
Rasio P/E
-
Hasil dividen
-
Dalam berita
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (USD) | Des 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 17,62Â jt | -4,30% |
Biaya operasional | 24,72Â jt | -5,23% |
Penghasilan bersih | -11,62Â jt | -0,28% |
Margin laba bersih | -65,97 | -4,78% |
Penghasilan per saham | — | — |
EBITDA | -9,76Â jt | -2,23% |
Tarif pajak efektif | 0,15% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Des 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 18,18Â jt | -49,32% |
Total aset | 56,39Â jt | -29,25% |
Total liabilitas | 73,04Â jt | -2,89% |
Total ekuitas | -16,65 jt | — |
Saham yang beredar | 30,63 jt | — |
Harga terhadap nilai buku | -2,41 | — |
Tingkat pengembalian aset | -43,32% | — |
Tingkat pengembalian modal | -77,09% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Des 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | -11,62Â jt | -0,28% |
Kas dari operasi | -5,44Â jt | 32,71% |
Kas dari investasi | 11,00Â rb | -99,55% |
Kas dari pembiayaan | 248,00Â rb | -75,71% |
Perubahan kas bersih | -5,18Â jt | -12,86% |
Arus kas bebas | -5,30Â jt | -7,21% |
Tentang
Avita Medical is a clinical and commercial company developing and marketing a range regenerative medicine products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are ReNovaCell, for Aesthetics and Plastic applications including skin trauma, and ReGenerCell for the treatment of chronic wounds. The Avita Medical regenerative product range is currently marketed in Europe, the Middle East, Africa and Australia. Wikipedia
Didirikan
1999
Kantor pusat
Situs
Karyawan
226
